The past 30 years have witnessed a substantial and growing interest in drug sensitization, particularly relating to the psychoactive and appetitive properties of psychostimulant and opiate drugs. It is now well established that rats repeatedly exposed to amphetamine, for example, will exhibit an enhanced-sensitized-locomotor response when subsequently challenged with the drug some time later. It is also well established that in these rats, the ability of amphetamine to increase extracellular levels of dopamine (DA) in forebrain is also enhanced. There have been many reports of such effects with a number of abused drugs from these two drug classes (for references and critical reviews of the pre-clinical literature, see Kalivas and Stewart, 1991; Vanderschuren and Kalivas, 2000; Vezina, 2004) . Of particular note, these effects are long lasting in the rat: up to one year following drug exposure for locomotion (Paulson et al., 1991) and up to three months for DA overflow (Hamamura et al., 1991) -the longest withdrawal periods tested. Indeed, amphetamine-induced nucleus accumbens DA overflow increases with time after exposure to the drug (Fig. 1) .
Given the critical role played by the mesoaccumbens DA pathways in the generation of appetitive behaviors including the pursuit and self-administration of abused drugs, it follows that altered activity in these pathways could affect the appetitive behavioral output of the organism. The incrementing and long lasting changes in nucleus accumbens DA overflow observed in rats following exposure to sensitizing drug regimens suggest that such effects on behavior can be long lasting. Such possibilities have fueled a large number of systems, cellular and molecular biological level investigations of the mechanisms that might underlie altered reactivity in midbrain DA neurons and those systems they interact with. On the other hand, while there is general agreement that drug sensitization can be demonstrated in some preparations, there has been less consensus as to whether and how sensitization might impact the generation of appetitive behaviors either within or between species.
This special issue highlights evidence obtained in rodents, non-human primates and humans that supports a role for sensitization in the generation of states that promote or are related to enhanced drug taking. This evidence is reviewed in the context of different data sets, interpretations and models from the clinical and pre-clinical literature with the goal of understanding and integrating sometimes apparently disparate views.
Drug addiction is characterized by compulsive drug taking that persists despite escalating costs and adverse consequences.
Over the past 20 years, sensitization of the appetitive effects of drugs has emerged as a possible mechanism underlying enhanced drug use (Robinson and Berridge, 1993, 2003) . However, a review of the pre-clinical literature reveals findings apparently for and against this view. It is now well established that manipulations leading to sensitization of locomotion and nucleus accumbens DA overflow also facilitate the acquisition of drug taking behaviors and increase the work animals will emit to self-administer a drug (Vezina, 2004) . On the other hand, other procedures known to lead to an escalation of drug intake, such as providing rats with daily 6-h vs 1-h access to the drug, are not associated with sensitization of locomotion or nucleus accumbens DA overflow (Ahmed et al., 2003) . Rather, this escalation in drug taking has been attributed to incremental recruitment of opponent-processes (Koob and Le Moal, 1997). In their review of the effects of nicotine exposure, Vezina et al. (2007-this issue) note that the effects observed following drug exposure are determined by at least two interrelated factors: the intensity of the drug exposure regimen and the time of testing following exposure. They propose a view of drug addiction that integrates opponent-process and sensitization components of drug exposure, with the former observed soon after exposure to sufficiently intense drug regimens when withdrawal symptoms are prevalent, and the latter appearing long after exposure once drug withdrawal symptoms have abated. Roberts et al. (2007-this issue) explore further the conditions that lead to enhanced motivation to self-administer drug. Using the progressive ratio schedule of reinforcement, they found that cocaine selfadministration using a number of access procedures does not in and of itself lead to enhanced work output. Interestingly, rats given access to binge-abstinence access procedures modeling patterns of cocaine use in humans do exhibit progressively increasing motivation to self-administer cocaine. These findings have important clinical implications because they begin to identify those characteristics of active drug exposure (as opposed to more commonly tested passive drug exposure) that lead to progressive increases in the motivation to seek and self-administer drugs.
The clinical literature supporting a role for sensitization in human drug use has also been equivocal. This has led to arguments that drug sensitization as a mechanism for drug abuse is of limited value as it does not extend to the human case. For example, imaging studies using PET and fMRI techniques have generally shown a profile in limbic regions of reduced rather 
